ABGNX
Price
$21.09
Change
-$0.05 (-0.24%)
Updated
Oct 7 closing price
Net Assets
914.59M
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

ABGNX vs RLBAX

Header iconABGNX vs RLBAX Comparison
Open Charts ABGNX vs RLBAXBanner chart's image
American Century Balanced R5
Price$21.09
Change-$0.05 (-0.24%)
VolumeN/A
Net Assets914.59M
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
ABGNX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
ABGNX vs. RLBAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABGNX is a Buy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. ABGNX (915M). ABGNX pays higher dividends than RLBAX: ABGNX (1.99) vs RLBAX (1.10). ABGNX was incepted earlier than RLBAX: ABGNX (9 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than ABGNX (0.69). ABGNX is a more actively managed with annual turnover of: 72.00 vs. RLBAX (44.00). ABGNX has a lower initial minimum investment than RLBAX: ABGNX (0) vs RLBAX (250). ABGNX (9.24) and RLBAX (9.12) have marching annual gain over last year. RLBAX return over 5 years is better than : 38.04 vs. ABGNX (11.23).
ABGNXRLBAXABGNX / RLBAX
Total Expense Ratio0.691.3153%
Annual Report Gross Expense Ratio0.691.3153%
Fund Existence9 years23 years-
Gain YTD8.80013.77064%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets915M266B0%
Annual Yield % from dividends1.991.10181%
Returns for 1 year9.249.12101%
Returns for 3 years48.4247.98101%
Returns for 5 years11.2338.0430%
Returns for 10 yearsN/A68.72-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group